SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

79,310.01 2,008.61
( 2.60%)

Global Indices

Nasdaq

53,347.89 1,540.17
(2.97%)

Dow Jones

7,717.41 127.49
(1.68%)

Hang Seng

60,935.13 -1,253.50
(-2.02%)

Nikkei 225

10,776.27 -52.94
(-0.49%)

Forex

USD-INR

94.73 -0.07
(-0.07%)

EUR-INR

105.99 -0.12
(-0.11%)

GBP-INR

127.06 -0.04
(-0.03%)

JPY-INR

0.60 0.00
(-0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

97.3802066

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

122.06

426121.89

EPS(TTM)

Face Value()

Div & Yield %

14.55

0.9

Back

Shankara Buildpro consolidated net profit rises 56.85% in the September 2026 quarter

Nov 05,2026

Net profit of Shankara Buildpro rose 56.85% to Rs 46.05 crore in the quarter ended September 2026 as against Rs 29.36 crore during the previous quarter ended September 2025. Sales rose 42.97% to Rs 2280.38 crore in the quarter ended September 2026 as against Rs 1595.02 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	2280.38	1595.02	43
OPM %	3.40	3.14	-
PBDT	65.46	40.96	60
PBT	62.00	38.95	59
NP	46.05	29.36	57

79,310.01 2,008.61 ( 2.60%)

53,347.89 1,540.17 (2.97%)

7,717.41 127.49 (1.68%)

60,935.13 -1,253.50 (-2.02%)

10,776.27 -52.94 (-0.49%)

94.73 -0.07 (-0.07%)

105.99 -0.12 (-0.11%)

127.06 -0.04 (-0.03%)

0.60 0.00 (-0.31%)